T1DM Self-Management Varies With Adult Developmental Stages

Share this content:
T1DM Self-Management Varies With Adult Developmental Stages
T1DM Self-Management Varies With Adult Developmental Stages

THURSDAY, May 31, 2018 (HealthDay News) -- Type 1 diabetes self-management behaviors vary across adult developmental stages, according to a study published online May 25 in Diabetes Care.

Margaret M. McCarthy, Ph.D., from the New York University Rory College of Nursing in New York City, and Margaret Grey, Dr.P.H., R.N., from the Yale School of Nursing in Orange, Conn., examined patterns of diabetes self-management behaviors and predictors of glycemic control in 7,153 adults enrolled in the Type 1 Diabetes Exchange clinic registry. Participants were classified into four adult developmental stages: emerging (age 18 to <25 years), young (age 25 to <45 years), middle-aged (age 45 to <65 years), and older adults (age ≥65 years).

The researchers found that emerging adults and older adults had the highest and lowest mean hemoglobin A1c levels, respectively (8.4 ± 1.7 percent and 7.3 ± 0.97 percent, respectively). The likelihood of using an insulin pump or continuous glucose monitor was lower for emerging adults (56 and 7 percent, respectively), and emerging adults were more likely to miss at least one insulin dose per day and have had an episode of diabetic ketoacidosis in the past year (3 and 7 percent, respectively). In each age group, different factors were associated with hemoglobin A1c ≥7 percent; the frequency of blood glucose checks and missed insulin doses were factors noted across several groups.

"When discussing diabetes self-management, providers may consider a patient's developmental stage, with its competing demands, such as work and family; psychosocial adjustments; and the potential burden of comorbidities," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves First Customizable Insulin Pump

FDA Approves First Customizable Insulin Pump

Product works by delivering insulin under the skin at set or variable rates

Sepsis Common in Terminal Hospitalizations, Discharges

Sepsis Common in Terminal Hospitalizations, Discharges

Most common underlying causes of death in sepsis are solid and hematologic cancers, chronic heart disease

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer Older Men Assessed, Treated for Osteoporosis

Fewer older men than women, even with higher risk, undergo DXA screening, 25(OH)D measurement

is free, fast, and customized just for you!




Already a member?

Sign In Now »